JPRN-UMIN000005697已完成未知
Phase I/II Study of Capecitabine in Combination with Peginterferon Alfa-2a for Patients with Advanced Hepatocellular Carcinoma - Phase I/II Study of Capecitabine in Combination with Peginterferon Alfa-2a for Patients with Advanced Hepatocellular Carcinoma
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with a history of malignancy. 2) Corresponding to the sever heart disease. 3) Active clinically-serious infections. 4) History of HIV infection. 5) Hemodialysis. 6) Clinical or radiological evidence of CNS metastases. 7) Uncontrollable massive ascites, pleural effusion. 8) Clinically-significant gastrointestinal bleeding within 4 weeks prior to study entry. 9) Severe allergy for fluoropyrimidines. 10) HBV-DNA positive and not being treated with nucleotide analogues. 11) Anticoagulant therapy with warfarin potassium. 12) During treatment with Tegafur gimeracil oteracil potassium, or within 7 days after discontinuation. 13) Use Sho-saiko-to. 14) Use oral phenytoin. 15) Severe thyroid disease.
研究者
相似试验
进行中（未招募）
不适用
A phase II study of Capecitabine in combination with Cisplatin in advanced head and neck Cancer - NDAdvanced or metastatic head and neck cancerLevel: HLTClassification code 10024530EUCTR2006-003775-13-ITOSPEDALE ONCOLOGICO DI BARI43
进行中（未招募）
不适用
A phase II study of Capecitabine in combination with oral vinorelbine in advanced Breast Cancer - NDEUCTR2006-003752-38-ITOSPEDALE ONCOLOGICO DI BARI
已完成
1 期
Phase I study of a combination of capecitabine plus CPT-11 (CC therapy) in patients with metastatic colon cancer refractory to oxaliplatin containing chemotherapyColorectal cancerJPRN-UMIN000003176Osaka Medical Center for Cancer and Cardiovascular Diseases24
已完成
1 期
Capecitabine and erlotinib in advanced lung cancerCancerISRCTN18199864Royal Marsden NHS Foundation Trust40
进行中（未招募）
不适用
Phase I/II Studie zum Einsatz von Capecitabin und Oxaliplatin (XELOX) in Kombination mit Bevacizumab und Imatinib in der Erstlinientherapie von Patienten mit fortgeschrittenem kolorektalem Karzinomfortgeschrittenes kolorektalen Karzinom mit inoperablen MetastasenMedDRA version: 9.1Level: LLTClassification code 10010035Term: Colorectal cancer stage IVEUCTR2007-000233-18-DEniversität zu Köln